Creso Pharma has expanded its distribution agreement with nutritional supplements company Route2 Pharm to enable its hemp-derived therapeutic products to be sold under the Cannaqiz and Cannadol brands in Ecuador.

The move gives the company access to the rapidly growing Latin American CBD market which is expected to grow to more than US$300 million by 2024.

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Vel turpis nunc eget lorem dolor sed. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh. Nisl nunc mi ipsum faucibus vitae.

Prior to launching Cannabiz, Martin was co-founder and CEO of Asia-Pac’s leading B2B media and marketing information brand Mumbrella, overseeing its sale to Diversified Communications in 2017. A journalist...

Leave a comment